Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CORAL LAB.   TEVA PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-23
TEVA PHARMA
Dec-13
CORAL LAB./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3683,486-   
Low Rs2173,028-   
Sales per share (Unadj.) Rs218.82,000.5-  
Earnings per share (Unadj.) Rs18.1125.0-  
Cash flow per share (Unadj.) Rs24.2286.7-  
Dividends per share (Unadj.) Rs0109.40-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs433.62,222.2-  
Shares outstanding (eoy) m3.57848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.31.6 82.2%   
Avg P/E ratio x16.226.1 62.2%  
P/CF ratio (eoy) x12.111.4 106.6%  
Price / Book Value ratio x0.71.5 46.1%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m1,0452,761,843 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1110-   
Avg. sales/employee Rs Th037,744.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,357.9-  
INCOME DATA
Net Sales Rs m7811,696,422 0.0%  
Other income Rs m690-   
Total revenues Rs m8501,696,422 0.1%   
Gross profit Rs m39464,566 0.0%  
Depreciation Rs m22137,123 0.0%   
Interest Rs m333,320 0.0%   
Profit before tax Rs m82294,122 0.0%   
Minority Interest Rs m01,336 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-193,075 -0.0%   
Tax Rs m18-3,591 -0.5%   
Profit after tax Rs m64105,974 0.1%  
Gross profit margin %4.927.4 18.0%  
Effective tax rate %21.6-1.2 -1,773.1%   
Net profit margin %8.36.2 132.1%  
BALANCE SHEET DATA
Current assets Rs m1,2351,145,757 0.1%   
Current liabilities Rs m119999,197 0.0%   
Net working cap to sales %143.08.6 1,654.8%  
Current ratio x10.41.1 908.4%  
Inventory Days Days23191 254.3%  
Debtors Days Days1,09496 1,140.9%  
Net fixed assets Rs m508554,089 0.1%   
Share capital Rs m364,176 0.9%   
"Free" reserves Rs m1,5120-   
Net worth Rs m1,5481,884,403 0.1%   
Long term debt Rs m0867,418 0.0%   
Total assets Rs m1,7433,876,868 0.0%  
Interest coverage x25.39.8 257.1%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.40.4 102.4%   
Return on assets %3.93.6 108.3%  
Return on equity %4.25.6 74.0%  
Return on capital %5.54.9 112.2%  
Exports to sales %92.10-   
Imports to sales %00-   
Net fx Rs m7060-   
CASH FLOW
From Operations Rs m127270,322 0.0%  
From Investments Rs m-26-95,786 0.0%  
From Financial Activity Rs m-64-324,269 0.0%  
Net Cashflow Rs m36-149,733 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.51 Rs / USD

Compare CORAL LAB. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CORAL LAB. With: PARNAX LAB  KABRA DRUGS  HEMO ORGANIC  MEDICAMEN BI  SHREE GANESH REMEDIES   



Today's Market

Gift Nifty Down 342 Points | Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today Gift Nifty Down 342 Points | Tata Motors to Make JLR Cars in Tamil Nadu | Kronox Lab Sciences to Launch IPO | Top Buzzing Stocks Today(Pre-Open)

It was indeed a volatile trading session for Indian share markets yesterday.